Literature DB >> 19253921

Pharmacovigilance in Traditional Chinese Medicine safety surveillance.

Hainan Wang1, Xiaofei Ye, Qingbin Gao, Cheng Wu, Yifeng Qian, Baozhang Luo, Yalin Sun, Jia He.   

Abstract

PURPOSE: To give an overview of the current status including problems and efforts about pharmacovigilance in Traditional Chinese Medicine (TCM) safety surveillance.
METHODS: It is based on literature review and publicly available data in China.
RESULTS: TCM led to several adverse drug reactions (ADRs) during the past few years and pharmacovigilance about TCM remained as a problem though great effort had been made to improve it.
CONCLUSIONS: Pharmacovigilance in TCM is still facing many challenges in playing critical roles in China. More attention should be paid to pharmacovigilance in TCM safety surveillance.

Mesh:

Year:  2009        PMID: 19253921     DOI: 10.1002/pds.1725

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  4 in total

1.  Methodological approaches to developing and establishing the body of evidence on post-marketing Chinese medicine safety.

Authors:  Xing Liao; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2013-07-02       Impact factor: 1.978

2.  Detecting drug-herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection.

Authors:  Haona Li; Jianxiong Deng; Zhihua Yue; Yiexiang Zhang; He Sun
Journal:  Eur J Clin Pharmacol       Date:  2015-07-11       Impact factor: 2.953

Review 3.  Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.

Authors:  Foon Yin Fung; Yeh Ching Linn
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-08       Impact factor: 2.629

4.  Identification of high-risk patients for ADR induced by traditional Chinese medicine injection: a nested case-control study.

Authors:  Cheng Jiang; Jie Shen; Dan Shou; Nani Wang; Jing Jing; Guodi Zhang; Jing Gu; Yunlong Tian; Caihua Sun; Jiaqi He; Jiaqi Ma; Xiaojun Wang; Gonghua Li
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.